Showing results (5401-5410 of 5,703) with videos related to
Sort By:
Pageof 571
The Oncologist|June 9, 2017
Efficacy and Safety of Pertuzumab and Trastuzumab Administered in a Single Infusion Bag, Followed by Vinorelbine: VELVET Cohort 2 Final ResultsMichael Andersson, José M López-Vega, Thierry Petit, et al.The Oncologist|June 9, 2017
Prolonged Pemetrexed Infusion Plus Gemcitabine in Refractory Metastatic Colorectal Cancer: Preclinical Rationale and Phase II Study ResultsAlessandro Passardi, Francesca Fanini, Livia Turci, et al.The Oncologist|June 9, 2017
Current Clinical Practice Guidelines for the Treatment of Renal Cell Carcinoma: A Systematic Review and Critical EvaluationAristotle Bamias, Bernard Escudier, Cora N Sternberg, et al.The Oncologist|May 11, 2017
Targeting BRAF-Mutant Non-Small Cell Lung Cancer: From Molecular Profiling to Rationally Designed TherapyChristina S Baik, Nathaniel J Myall, Heather A WakeleeThe Oncologist|May 11, 2017
Geriatric Assessment Predicts Survival and Competing Mortality in Elderly Patients with Early Colorectal Cancer: Can It Help in Adjuvant Therapy Decision-Making?Maite Antonio, Juana Saldaña, Alberto Carmona-Bayonas, et al.The Oncologist|April 28, 2018
Representation of Minorities and Elderly Patients in Multiple Myeloma Clinical TrialsNarjust Duma, Tariq Azam, Irbaz Bin Riaz, et al.The Oncologist|April 28, 2018
Comprehensive Molecular Characterization of Young Chinese Patients with Lung Adenocarcinoma Identified a Distinctive Genetic ProfileHelei Hou, Hua Zhu, Han Zhao, et al.The Oncologist|April 28, 2018
Genomic Profiling of HER2-Positive Gastric Cancer: PI3K/Akt/mTOR Pathway as Predictor of Outcomes in HER2-Positive Advanced Gastric Cancer Treated with TrastuzumabAsunción Díaz-Serrano, Barbara Angulo, Carolina Dominguez, et al.The Oncologist|April 29, 2018
Immuno-Oncology Biomarkers for Gastric and Gastroesophageal Junction Adenocarcinoma: Why PD-L1 Testing May Not Be EnoughBenjamin A Weinberg, Joanne Xiu, Jimmy J Hwang, et al.Pageof 571